Startup Business Strategy, Setting Yourself Apart By Stephen Tyrpak | February 13, 2024 Stephen is the VP of Operations; US & Canada, Local Equity Partner at PQE Group. He loves [….]
Startup Business Strategy, Setting Yourself Apart
How to Network with Investors
How to Network with Investors: JLABS@DC. Networking with investors is a vital part of growing a life science startup company.
How Biotech Companies Can Leverage Marketing to Boost Investment Goals
Marketing is essential for early-stage biotechnology companies to secure funding. To succeed, the following strategies can enhance fundraising efforts while increasing a company’s visibility.
BioSpark Virginia
BioSpark Virginia is a competitive live pitch event for Virginia life sciences start-ups, co-sponsored and organized by CvilleBioHub and the University of Virginia Licensing and Ventures Group (LVG). After an [….]
Pitch Perfected: Best Practices in Pitching & Presenting for Life Science Startups
A chance to pitch to an investor or potential partner is a golden opportunity for a biotech startup. It’s also a pressure-packed moment where every minute counts. No matter how [….]
How Biotech and Life Science Startups Can Embrace Digital Technology to Get Ahead
Whether they are building a new healthcare IT system from scratch or a groundbreaking medical device, many biotech and life science startups need easy-to-use tools specifically designed to help streamline agile projects and/or manage the entire software lifecycle.
Doogie and the Rock Star: BioFactura’s Remarkable Journey
BioFactura, a leading developer and manufacturer of biosimilars and biodefense products, is one of the crown jewels of Frederick, Maryland’s growing biotech hub. The company is thriving and has secured strong funding from both private and government sources that see the potential of the company’s StableFast™ biosimilars platform. In May 2021, BioFactura reached an important milestone, announcing that it had moved its first biosimilar product into the clinic.
Secretary of Commerce tours new I-270 Innovation Labs, flexible lab space meeting critical industry need
From left to right: Kelly Shultz – Secretary of Commerce, State of Maryland; Luis Rugeles – Co-founder & CEO, I-270 Innovation Labs; and Doug Bane – Co-founder & COO, I-270 Innovation Labs.
5 Questions With Julie Lenzer, Chief Innovation Officer, University of Maryland
A serial entrepreneur and ecosystem builder, Julie Lenzer is currently the Chief Innovation Officer at the University of Maryland and Founding Director for the newly-launched Quantum Startup Foundry. In these roles, she is charged with fostering and deploying innovation to drive economic and social impact from both university-affiliated and community-based innovators and oversees the university’s tech transfer office, the Maryland Small Business Development Center (SBDC), the Veteran’s Business Outreach Center (VBOC), the Mixed/Augmented/Virtual Reality Innovation Center (MAVRIC), as well as university engagement with the Discovery District (UMD’s 150-acre research park). An active angel investor, she is also on the investment committee of the $10M Maryland Momentum Fund and UMD’s newly-launched Discovery Fund.
The Benefits of Taking Your Career to a Growth Stage Biotech
Over the next few years, thousands of new positions in the biopharma and life sciences industry are expected to open up across the BioHealth Capital Region and the greater Philadelphia area known as Cellicon Valley.
Whether you are fresh out of the university or a seasoned veteran, many job seekers question whether or not they should aim for large biopharmaceutical companies, such as AstraZeneca, Pfizer or GlaxoSmithKline, or look at nimble, growth-stage companies, such as American Gene Technologies, Vita Therapeutics, or BioFactura, Inc., which is currently scaling their cGMP and Quality operations.